GlassScriptPhysician profile
Sherryl A Ashberg
NPI 1104827229
$2,447.22
in general payments reported to CMS, 2019-2025
19 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $601 · 2021: $617 · 2022: $123 · 2023: $125 · 2024: $15.46 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $802.61 | 2019-2022 | |
| Amgen INC. | $260.94 | 2019-2025 | Evenity |
| Lilly USA, LLC | $249.98 | 2023-2025 | Mounjaro |
| Pfizer INC. | $196.86 | 2019-2024 | |
| Allergan, INC. | $188.26 | 2019-2020 | |
| Stryker Corporation | $164.36 | 2021 | |
| Abbvie INC. | $146.77 | 2021 | |
| Kvk-Tech, INC. | $99.16 | 2019-2021 | |
| Amarin Pharma, INC. | $99.06 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.52 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $30.37 | 2019 | |
| Glaxosmithkline, LLC. | $29.71 | 2019-2020 | |
| Boston Scientific Corporation | $29.20 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $29.01 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.17 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.83 | 2019 | |
| Eisai INC. | $15.40 | 2020 | |
| Seqirus USA INC | $11.94 | 2019 | |
| Shire North American Group INC | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherryl Ashberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.